| abstract |
The present invention discloses the application of 5α-androst-3β,5,6β triol and its analogs, deuterates or pharmaceutically acceptable salts thereof in the manufacture of drugs for the treatment of cerebrovascular diseases in patients. The cerebrovascular disease is preferably brain microbleeding. The brain microbleeding is spontaneous brain microbleeding, drug-related brain microbleeding, or traumatic brain microbleeding. The present invention demonstrates that these compounds can be used to treat cerebrovascular diseases by significantly increasing the removal of hemoglobin outside blood vessels. |